Volume 13, Issue 9, Pages (December 2015)

Slides:



Advertisements
Similar presentations
Tzachi Hagai, Ariel Azia, M. Madan Babu, Raul Andino  Cell Reports 
Advertisements

Volume 16, Issue 8, Pages (August 2016)
A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures  Gang Wang, Na Zhao, Ben Berkhout, Atze.
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Intrinsic Cellular Defenses against Human Immunodeficiency Viruses
Volume 14, Issue 1, Pages (July 2013)
Volume 3, Issue 1, Pages (July 2016)
Ping Wang, Katelyn A. Doxtader, Yunsun Nam  Molecular Cell 
Volume 24, Issue 7, Pages (July 2016)
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 12, Issue 4, Pages (October 2012)
Volume 12, Issue 11, Pages (September 2015)
Volume 21, Issue 6, Pages (June 2013)
Silvestro G Conticello, Reuben S Harris, Michael S Neuberger 
Volume 16, Issue 5, Pages (August 2016)
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface
Volume 21, Issue 9, Pages (September 2013)
Xiaojing He, Yi-Chun Kuo, Tyler J. Rosche, Xuewu Zhang  Structure 
Volume 2, Issue 2, Pages (August 2002)
Sherilyn Grill, Valerie M. Tesmer, Jayakrishnan Nandakumar 
HIV-1 Vpu Mediates HLA-C Downregulation
Volume 18, Issue 11, Pages (November 2010)
Volume 36, Issue 4, Pages (November 2009)
Volume 16, Issue 8, Pages (August 2016)
Volume 19, Issue 3, Pages (March 2011)
Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure  C. Suñé, L. Brennan, D.R. Stover,
Volume 11, Pages (January 2019)
Scot A Wolfe, Elizabeth I Ramm, Carl O Pabo  Structure 
A Solution to Limited Genomic Capacity: Using Adaptable Binding Surfaces to Assemble the Functional HIV Rev Oligomer on RNA  Matthew D. Daugherty, Iván.
Crystal Structure of the Human High-Affinity IgE Receptor
Volume 69, Issue 1, Pages e9 (January 2018)
Zijing Chen, Hsiang-Chin Chen, Craig Montell  Cell Reports 
Volume 128, Issue 3, Pages (February 2007)
Volume 20, Issue 1, Pages 9-19 (October 2005)
Adam S. Dingens, Hugh K. Haddox, Julie Overbaugh, Jesse D. Bloom 
The Host Restriction Factor APOBEC3G and Retroviral Vif Protein Coevolve due to Ongoing Genetic Conflict  Alex A. Compton, Vanessa M. Hirsch, Michael.
Error-Prone DNA Polymerases
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
Tzachi Hagai, Ariel Azia, M. Madan Babu, Raul Andino  Cell Reports 
Volume 51, Issue 1, Pages (July 2013)
Volume 15, Issue 3, Pages (April 2016)
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 8, Issue 4, Pages (October 2010)
David Jeruzalmi, Mike O'Donnell, John Kuriyan  Cell 
Volume 114, Issue 3, Pages (February 2018)
Volume 12, Issue 1, Pages (July 2015)
Volume 9, Issue 1, Pages (January 2011)
APOBEC Enzymes as Targets for Virus and Cancer Therapy
Adaptive Evolution of MERS-CoV to Species Variation in DPP4
MELK Promotes Melanoma Growth by Stimulating the NF-κB Pathway
Volume 20, Issue 10, Pages (September 2017)
Volume 15, Issue 6, Pages (June 2007)
Volume 12, Issue 3, Pages (September 2012)
Volume 87, Issue 7, Pages (December 1996)
Volume 23, Issue 1, Pages (January 2015)
Structural and Mechanistic Analysis of the Slx1-Slx4 Endonuclease
Guilty as charged Cancer Cell
Matthieu Chavent, Elena Seiradake, E. Yvonne Jones, Mark S.P. Sansom 
APOBEC Enzymes as Targets for Virus and Cancer Therapy
Parul Mishra, Julia M. Flynn, Tyler N. Starr, Daniel N.A. Bolon 
Cardiolipin Interactions with Proteins
Volume 6, Issue 3, Pages (February 2014)
Volume 7, Issue 2, Pages R19-R23 (February 1999)
Volume 14, Issue 15, Pages (August 2004)
by Brett D. Anderson, and Reuben S. Harris
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Qing Yao, Sara J. Weaver, Jee-Young Mock, Grant J. Jensen  Structure 
Structural Basis of SOSS1 Complex Assembly and Recognition of ssDNA
Volume 17, Issue 5, Pages (October 2016)
Presentation transcript:

Volume 13, Issue 9, Pages 1781-1788 (December 2015) The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches  Christopher Richards, John S. Albin, Özlem Demir, Nadine M. Shaban, Elizabeth M. Luengas, Allison M. Land, Brett D. Anderson, John R. Holten, John S. Anderson, Daniel A. Harki, Rommie E. Amaro, Reuben S. Harris  Cell Reports  Volume 13, Issue 9, Pages 1781-1788 (December 2015) DOI: 10.1016/j.celrep.2015.10.067 Copyright © 2015 The Authors Terms and Conditions

Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions

Figure 1 HIV-1 Adaptation to Vif-Resistant A3F (A) A schematic depicting the co-culture selection strategy used to adapt HIV-1 to Vif-resistant A3F-expressing cells as the selective pressure. Viruses were passaged stepwise approximately every 8–11 days from permissive to increasingly non-permissive cultures as shown. Upon completing a round of selection from fully permissive to fully non-permissive cultures, portions of each culture were cycled back to the beginning of the process for another round of selection. (B) Anti-A3F immunoblot of SupT11-derived T cell lines stably expressing huA3F, A3F QE323-324EK, or empty vector (relative protein expression levels as follows: L, low; M, medium; H, high; VH, very high; and V, empty vector). A3F levels in HIV-1-infected primary T cell and H9 lysates are shown for comparison. (C) Bar graphs indicating the number of independent times that each of the indicated HIV-1 IIIB or LAI Vif amino acid changes were observed. The x axis is a to-scale depiction of Vif residues 1–192 with previously reported motifs indicated below for reference. In most instances, HIV-1IIIB and HIV-1LAI had the same amino acid change at a given position with the exception of HIV-1IIIB E117K and HIV-1LAI D117N for both A3F QE323-324EK and rhA3F selective conditions (shown explicitly in the figure). Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions

Figure 2 HIV-1 Vif G71D Enables Viral Infectivity in the Presence of Vif-Resistant A3F (A) Single-cycle infectivity data for Vif-null HIV-1IIIB produced in the presence of huA3F, huA3F E324K, or rhA3F and the indicated amounts of Vif G71 (wild-type) or Vif D71 (adapted) expression constructs. Immunoblots are shown below for Vif (anti-HA), A3F (anti-V5), and tubulin (anti-TUB). (B) Spreading infection data are shown for HIV-1IIIB stocks with the indicated Vif alleles in SupT11 clones expressing zero (empty vector), low, medium, or high levels of huA3F or huA3F E324K. (C) Anti-A3F immunoblot of SupT11-derived T cell lines stably expressing huA3F or A3F E324K. Empty vector-transfected SupT11 clones V1 and V2 and the non-permissive T cell line H9 are shown for comparison. Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Vif-A3F Interaction Model (A) A ribbon schematic of HIV-1 Vif highlighting residues D14, R15, M16, R17, and G71. D14 is the first residue of an α helix containing Vif residues 14–31, which includes the DRMR motif. Vif G71 is located in a nearby loop on the same surface of the structure (PDB: 4N9F). Vif is colored cyan and a faded surface representation of CBF-β is shown in green to facilitate visualization. (B) A ribbon schematic shows the Vif-binding domain of huA3F, highlighting the α3 and α4 helices and the position of residue E324 near the end of the α4 helix (PDB: 4IOU). (C) A model of the complex generated by docking A3Fctd onto Vif. In this initial docked model, direct interactions occur between A3F E324 and Vif G71 as well as A3F E289 and R15. (D) An MD simulation-optimized model of the A3F-Vif macromolecular complex. Residues E289 and R15 form a strong persistent interaction, and residues within the Vif G71-containing loop are interacting with A3F residues between helices α2 and α3. See the main text for details. Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions

Figure 4 HIV-1 Vif-A3F Interface Interactions Validated by Gain-of-Function Viral Infectivity Experiments (A) Single-cycle infectivity data for Vif-null HIV-1IIIB produced in the presence of huA3F, huA3F E324K, or huA3F E289K and the indicated amounts of Vif R15 (wild-type) or Vif E15 expression constructs. Each histogram bar shows the average infectivity from three independent experiments (mean ± SEM). Statistical significance was determined by two-way ANOVA followed by a post hoc Bonferroni test to determine significance between or within testing groups (p values of less than 0.05 were considered significant). Immunoblots are shown below for virus-like particles (anti-A3F and anti-P24) and producer cell lysates (anti-A3F, anti-Vif, and anti-TUB). (B) Spreading infection data demonstrate that HIV-1 encoding Vif R15E replicates on SupT11 that stably expresses A3F E289K, whereas HIV-1 IIIB Vif cannot establish a productive infection in identical culture conditions. SupT11-derived T cell lines used for these spreading infections have been stably transfected with huA3F, A3F E289K, or a vector. A3F protein expression in H9 lysates is shown for comparison. Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions

Figure 5 Wobble Model to Explain the Evolution of the Vif-A3 Interaction The schematic shows the wobble model for adaptation of the Vif side of the Vif-A3 interface. Each hexagon of the lattice depicts a potential interaction as follows: ancestral, dark gray; potential, light blue; attenuated, light gray; A3F, orange; and A3G, purple. The model predicts that the ancestral Vif-A3 interaction was strong and consisted of six interaction points (arbitrary number for discussion purposes). Viral transmission to a new host with a larger A3 repertoire results in diminished but still partly functional interactions. A series of rapid adaptations (possibly most or all in the original new host) restores the strong interaction and results in partly overlapping interaction surfaces. Then, over a much longer evolutionary period, the combined effect of many independent wobbles triggered by virus or host genetic changes could result in the present day non-overlapping surfaces of Vif that interact with A3F and A3G. Similar rules would apply to other HIV-1-restrictive A3s (not shown for simplicity). A strong interaction may be disrupted by a viral or host amino acid substitution mutation, but the overall interaction can be restored by a compensatory change in Vif at the same site, nearby, or even to extend the edge of an interaction surface. If this change occurs at a new position, it can be considered a wobble. A series of wobbles over evolutionary time can account for a shift in the entire interaction surface. Cell Reports 2015 13, 1781-1788DOI: (10.1016/j.celrep.2015.10.067) Copyright © 2015 The Authors Terms and Conditions